Shanghai Minwei Biotechnology Co., Ltd
Clinical trials sponsored by Shanghai Minwei Biotechnology Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Oral pill aims to keep weight off after initial loss Results expected Sep 2026 (estimated)
- Can a new injection help tackle obesity? a trial puts MWN105 to the test Results expected Oct 2026 (estimated)
- Can a new injection help people shed significant weight? Results expected Oct 2026 (estimated)
- Can one shot tame high blood pressure? Results expected Oct 2026 (estimated)
- New injection aims to tackle high cholesterol in early human trial Results expected Oct 2026 (estimated)
-
Oral pill aims to keep weight off after initial loss
Disease control OngoingThis phase 2 trial tests whether MWN109 tablets can help non-diabetic adults with overweight or obesity maintain weight loss over 24 weeks. Participants who already lost at least 5% of their body weight in a prior study will take the tablet either once daily or once weekly. Resea…
Phase 2 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection help people shed significant weight?
Disease control OngoingThis trial tests whether MWN109, an investigational injection, can help non-diabetic adults with overweight or obesity lose weight. About 125 participants will receive either MWN109 or a placebo once a week for 36 weeks. The main goal is to see how much body weight changes from t…
Phase 2 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a single injection quiet harmful blood fats?
Knowledge-focused OngoingThis early-stage trial tests whether a single injection of MWX203 is safe and tolerable in healthy adults aged 18 to 55. Participants must have slightly elevated cholesterol and triglycerides, but not high enough to require medication. The study gives different doses to different…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC